One of the biggest challenges for transplant patients is knowing whether their new organ is being rejected before it’s too late. Rejection happens silently – the immune system attacks the donated organ without obvious warning signs until significant damage has occurred. Now, researchers are testing a simple but clever solution: a small patch of donor skin grafted onto the arm that can show rejection days or weeks before traditional tests would.
What is the skin patch system?
Scientists have discovered that skin tissue from a donor rejects more visibly and more quickly than other transplanted organs. When rejection begins, it shows as a rash or colour change on the skin – something the patient can literally see every day without needing blood tests or X-rays.
In a trial by the University of Oxford and NHS Blood and Transplant, lung transplant patients are receiving a small graft of skin from their donor placed on their arm. If the patient’s immune system begins to reject the new lung, the same rejection process will show up on the skin patch first. The patient or their doctor can spot the warning sign – a visible rash – and start aggressive treatment immediately, before the lung is significantly damaged.
This is a genuine advantage: lung transplants have a particularly high rejection rate, and it’s often difficult to distinguish rejection from infection in the early stages. A visible, unmistakable warning sign changes everything.
You can read the full original article from BBC News here: Arm skin patch system could warn of organ rejection.
Why this matters for kidney patients
Whilst the current trial focuses on lung transplants, the principle applies to all transplant patients – including those with kidney transplants. Early detection of rejection is crucial. The sooner treatment begins, the more likely it is that the new organ can be saved. Every week that rejection goes undetected increases the risk of permanent damage.
Currently, kidney transplant patients rely on blood tests to monitor their kidney function and detect rejection. These tests are valuable, but they can be delayed – a patient might not have a test scheduled for weeks, and rejection can progress in that time. A visible skin patch offers something traditional tests don’t: immediate, continuous monitoring that the patient can check themselves.
Simple, visible tools like the skin patch remind us that sometimes the most effective solutions are the ones that bring patients into the monitoring process as active partners.
– Guy Hill, Chair of MRIKPA
What this does – and does not – mean right now
The skin patch trial is currently enrolling 152 lung transplant patients in England. Early results are promising: patients who received the skin graft have shown lower rejection rates than expected. But the trial is still ongoing, and larger studies will be needed to confirm the approach and expand it to other transplant types, including kidney transplants.
It’s important to understand that the skin patch is not a replacement for regular blood tests and clinical monitoring. It’s an additional tool that helps catch rejection earlier. Transplant patients will still need to attend their regular appointments, have blood tests done, and maintain close contact with their transplant team.
If you’re a kidney transplant patient, continue to follow the monitoring schedule your transplant team has given you. If you notice any unusual symptoms or changes, contact your team immediately. And if future trials demonstrate that skin grafts could benefit kidney transplant patients too, your transplant team will discuss this with you.
For more information about living with a kidney transplant, explore our resources on transplant support or organ donation.
If you have questions about your transplant care, contact MRIKPA at support@mrikpa.org.uk or call 07745 242 684.
Source: University of Oxford and NHS Blood and Transplant. “Sentinel trial: Skin patch for early organ rejection detection,” 2024.
This article is provided for general information and awareness purposes only and was believed to be accurate at the time of publishing. It is not intended as medical advice – please always consult your doctor or renal team for guidance on your individual circumstances. Images used are for illustration purposes only and may not be medically or editorially accurate. While we take every care, errors can occur. If you spot an inaccuracy, please let us know at support@mrikpa.org.uk.
